The invention is aimed at nanoparticulate systems for the controlled
release of heparin. It is specifically aimed at nanoparticulate systems
comprising chitosan, heparin and optionally a polyoxyethylenated
derivative, and which are ionically cross-linked, as well as being aimed
at processes for obtaining them.